459 related articles for article (PubMed ID: 30293987)
1. Identification of clinically actionable variants from genome sequencing of families with congenital heart disease.
Alankarage D; Ip E; Szot JO; Munro J; Blue GM; Harrison K; Cuny H; Enriquez A; Troup M; Humphreys DT; Wilson M; Harvey RP; Sholler GF; Graham RM; Ho JWK; Kirk EP; Pachter N; Chapman G; Winlaw DS; Giannoulatou E; Dunwoodie SL
Genet Med; 2019 May; 21(5):1111-1120. PubMed ID: 30293987
[TBL] [Abstract][Full Text] [Related]
2. A Screening Approach to Identify Clinically Actionable Variants Causing Congenital Heart Disease in Exome Data.
Szot JO; Cuny H; Blue GM; Humphreys DT; Ip E; Harrison K; Sholler GF; Giannoulatou E; Leo P; Duncan EL; Sparrow DB; Ho JWK; Graham RM; Pachter N; Chapman G; Winlaw DS; Dunwoodie SL
Circ Genom Precis Med; 2018 Mar; 11(3):e001978. PubMed ID: 29555671
[TBL] [Abstract][Full Text] [Related]
3. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
[TBL] [Abstract][Full Text] [Related]
4. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium.
Amendola LM; Jarvik GP; Leo MC; McLaughlin HM; Akkari Y; Amaral MD; Berg JS; Biswas S; Bowling KM; Conlin LK; Cooper GM; Dorschner MO; Dulik MC; Ghazani AA; Ghosh R; Green RC; Hart R; Horton C; Johnston JJ; Lebo MS; Milosavljevic A; Ou J; Pak CM; Patel RY; Punj S; Richards CS; Salama J; Strande NT; Yang Y; Plon SE; Biesecker LG; Rehm HL
Am J Hum Genet; 2016 Jun; 98(6):1067-1076. PubMed ID: 27181684
[TBL] [Abstract][Full Text] [Related]
5. Experience with genomic sequencing in pediatric patients with congenital cardiac defects in a large community hospital.
Hauser NS; Solomon BD; Vilboux T; Khromykh A; Baveja R; Bodian DL
Mol Genet Genomic Med; 2018 Mar; 6(2):200-212. PubMed ID: 29368431
[TBL] [Abstract][Full Text] [Related]
6. Low-Pass Genome Sequencing: Validation and Diagnostic Utility from 409 Clinical Cases of Low-Pass Genome Sequencing for the Detection of Copy Number Variants to Replace Constitutional Microarray.
Chaubey A; Shenoy S; Mathur A; Ma Z; Valencia CA; Reddy Nallamilli BR; Szekeres E; Stansberry L; Liu R; Hegde MR
J Mol Diagn; 2020 Jun; 22(6):823-840. PubMed ID: 32344035
[TBL] [Abstract][Full Text] [Related]
7. Adapting ACMG/AMP sequence variant classification guidelines for single-gene copy number variants.
Brandt T; Sack LM; Arjona D; Tan D; Mei H; Cui H; Gao H; Bean LJH; Ankala A; Del Gaudio D; Knight Johnson A; Vincent LM; Reavey C; Lai A; Richard G; Meck JM
Genet Med; 2020 Feb; 22(2):336-344. PubMed ID: 31534211
[TBL] [Abstract][Full Text] [Related]
8. Genome sequencing as a first-line genetic test in familial dilated cardiomyopathy.
Minoche AE; Horvat C; Johnson R; Gayevskiy V; Morton SU; Drew AP; Woo K; Statham AL; Lundie B; Bagnall RD; Ingles J; Semsarian C; Seidman JG; Seidman CE; Dinger ME; Cowley MJ; Fatkin D
Genet Med; 2019 Mar; 21(3):650-662. PubMed ID: 29961767
[TBL] [Abstract][Full Text] [Related]
9. Utilization of Whole Exome Sequencing to Identify Causative Mutations in Familial Congenital Heart Disease.
LaHaye S; Corsmeier D; Basu M; Bowman JL; Fitzgerald-Butt S; Zender G; Bosse K; McBride KL; White P; Garg V
Circ Cardiovasc Genet; 2016 Aug; 9(4):320-9. PubMed ID: 27418595
[TBL] [Abstract][Full Text] [Related]
10. Targeted next-generation sequencing identifies pathogenic variants in familial congenital heart disease.
Blue GM; Kirk EP; Giannoulatou E; Dunwoodie SL; Ho JW; Hilton DC; White SM; Sholler GF; Harvey RP; Winlaw DS
J Am Coll Cardiol; 2014 Dec; 64(23):2498-506. PubMed ID: 25500235
[TBL] [Abstract][Full Text] [Related]
11. Genomic Analysis in the Age of Human Genome Sequencing.
Lappalainen T; Scott AJ; Brandt M; Hall IM
Cell; 2019 Mar; 177(1):70-84. PubMed ID: 30901550
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ACMG-Guideline-Based Variant Classification of Cancer Susceptibility and Non-Cancer-Associated Genes in Families Affected by Breast Cancer.
Maxwell KN; Hart SN; Vijai J; Schrader KA; Slavin TP; Thomas T; Wubbenhorst B; Ravichandran V; Moore RM; Hu C; Guidugli L; Wenz B; Domchek SM; Robson ME; Szabo C; Neuhausen SL; Weitzel JN; Offit K; Couch FJ; Nathanson KL
Am J Hum Genet; 2016 May; 98(5):801-817. PubMed ID: 27153395
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of targeted next-generation sequencing in fetuses with congenital heart defect.
Hu P; Qiao F; Wang Y; Meng L; Ji X; Luo C; Xu T; Zhou R; Zhang J; Yu B; Wang L; Wang T; Pan Q; Ma D; Liang D; Xu Z
Ultrasound Obstet Gynecol; 2018 Aug; 52(2):205-211. PubMed ID: 29536580
[TBL] [Abstract][Full Text] [Related]
14. Clinical Interpretation of Sequence Variants.
Zhang J; Yao Y; He H; Shen J
Curr Protoc Hum Genet; 2020 Jun; 106(1):e98. PubMed ID: 32176464
[TBL] [Abstract][Full Text] [Related]
15. [The updates of the ACMG variant interpretation guidelines affect the pathogenicity determination of
Wu KL; Li J; Wang HY; Wang QJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 59(5):455-463. PubMed ID: 38811176
[No Abstract] [Full Text] [Related]
16. Outcomes of 92 patient-driven family studies for reclassification of variants of uncertain significance.
Tsai GJ; Rañola JMO; Smith C; Garrett LT; Bergquist T; Casadei S; Bowen DJ; Shirts BH
Genet Med; 2019 Jun; 21(6):1435-1442. PubMed ID: 30374176
[TBL] [Abstract][Full Text] [Related]
17. Genomic sequencing identifies secondary findings in a cohort of parent study participants.
Thompson ML; Finnila CR; Bowling KM; Brothers KB; Neu MB; Amaral MD; Hiatt SM; East KM; Gray DE; Lawlor JMJ; Kelley WV; Lose EJ; Rich CA; Simmons S; Levy SE; Myers RM; Barsh GS; Bebin EM; Cooper GM
Genet Med; 2018 Dec; 20(12):1635-1643. PubMed ID: 29790872
[TBL] [Abstract][Full Text] [Related]
18. A systematic variant screening in familial cases of congenital heart defects demonstrates the usefulness of molecular genetics in this field.
El Malti R; Liu H; Doray B; Thauvin C; Maltret A; Dauphin C; Gonçalves-Rocha M; Teboul M; Blanchet P; Roume J; Gronier C; Ducreux C; Veyrier M; Marçon F; Acar P; Lusson JR; Levy M; Beyler C; Vigneron J; Cordier-Alex MP; Heitz F; Sanlaville D; Bonnet D; Bouvagnet P
Eur J Hum Genet; 2016 Feb; 24(2):228-36. PubMed ID: 26014430
[TBL] [Abstract][Full Text] [Related]
19. Exploring the clinical utility of exome sequencing/Mono, Duo, Trio in prenatal testing: a retrospective study in a tertiary care centre in South India.
Ilangovan H; Elangovan J; Danda S; Beck MM; Navaneethan P; Athiyarath R
J Perinat Med; 2024 Jun; 52(5):520-529. PubMed ID: 38709224
[TBL] [Abstract][Full Text] [Related]
20. Investigation of Genetic Causes in Patients with Congenital Heart Disease in Qatar: Findings from the Sidra Cardiac Registry.
Okashah S; Vasudeva D; El Jerbi A; Khodjet-El-Khil H; Al-Shafai M; Syed N; Kambouris M; Udassi S; Saraiva LR; Al-Saloos H; Udassi J; Al-Shafai KN
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
